OBAMACARE IS DEAD, WELCOME TRUMPCARE OPPORTUNITIES! $SPY $XLV $XHS $PJP $XBI $IHI $BMY $JNJ $PFE $MRK $ABT $ABBV $LLY $HUM $UNH $AET $ANTH $CI $HCE $CVH $THC $CNC $MOH

Democrats will fight tooth and nail to save Obamacare, but given the flaws in the plan, they are not likely to succeed. Obamacare in its current form is the walking dead. Trump has said that he ...
Read more »

INDIA COURT RULING AGAINST NOVARTIS IS DARK OMEN FOR BIG PHARMA $NVS $LLY $BMY $MRK $JNJ $PFE

It is official: India is siding with poor cancer patients over profits for multinational drug giants. The Supreme Court of India has rejected a plea by Swiss pharma giant Novartis that ends the seven-year legal battle to restrict Indian companies ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

26 WAYS TO PROFIT FROM ‘OBAMACARE’ $WLP $HCA $CYH $UHS $WCG $HUM $CNC $MRK $LLY $PFE $MDT $STJ

Obama has been re-elected; “Obamacare” is the law of the land. It doesn't matter if you agree or disagree with Obamacare, you might as well generate big profits from it. Obamacare has been profitable for us. ...
Read more »

OBAMA OR ROMNEY, PHARMA IS A LOSER

A popular axiom among long-only investors is to “buy low sell high.” For those investors who are equally interested in making money from both markets going up and markets going down, the parallel axiom is, “short-sell ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

FORGET LIPITOR, HERE COMES THE NEXT BIG THING

In 1971, a Japanese biochemist, Akira Endo, started work on what turned out to be the next big thing in the prevention of heart attacks and strokes, known as statins. In 1978, Merck (MRK) isolated lovastatin from fungusAspergillus ...
Read more »

CONSIDER PARTIAL BUY ON MRK (MERCK) TO LOCK IN PROFITS

Our methodology correctly predicted conditions at MRK as is evidenced by its earnings this morning. Consider start taking partial profits in $23.00 to $23.20 range or higher, depending on the size of your position. If ...
Read more »

CONSIDER SHORTING MRK (MERCK)

Merck had the best two day gain ever in its history. After a 38% gain, this afternoon smart money was selling in the wake of massive short covering as measured by our proprietary studies. The ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers

make money

327 WINNING TRADES

21 LOSING TRADES

1090.62% ANNUALIZED AVERAGE RETURN PER TRADE
Easily Verifiable

CLICK HERE TO

CHECK OUT FREE TRIALS

START GENERATING WEALTH NOW!